Fever did not abate. 4 weeks, the patient became afebrile and was discharged from hospital. Development of symptoms with respect to drug supervision, unexplained fever, negative workup for an infection, and noticeable response to corticosteroid therapy were found in our case. An explanation could be a delayed type of hypersensitivity (type IV) with activation of CD8 T cell which could possibly explain most of the symptoms. We have developed a decision algorithm Bax inhibitor peptide P5 in order to anticipate timely diagnosis of 5-azacitidine-induced pneumonitis, with the aim to limit antibiotics misuse and to set up emergency treatment. == Key Points == == Introduction == Pneumonitis, often called interstitial lung disease or ILD, is a possible manifestation of many antineoplastic and other drugs, with several ILD subtypes being explained in association with drugs. Pulmonary toxicity from 5-azacytidine, a deoxyribonucleic acid (DNA) methyltransferase inhibitor which also exerts cytotoxic effects, offers rarely been reported, although the drug continues to be used since 1982. 5-Azacytidine acts as a hypomethylating agent from the Y globin suppressor gene to induce fetal hemoglobin in thalassemia and, since 2000, to treat high-risk myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML) with low blast counts. Here, we report a case of 5-azacytidine-asociated pneumonitis, review the literature, and develop Bax inhibitor peptide P5 a diagnostic algorithm for this rare condition to avoid delay in medical care and misuse of antibiotics. == Case Report == A 67-year-old woman presented as an outpatient of our Hematology Department in August 2015 for progressive neutropenia, anemia, and fatigue. Peripheral blood examination showed a normochromic normocytic anemia with 9. 4 g/dL hemoglobin, 0. 350 109/L neutrophils and 138 109/L platelets. A bone marrow aspirate (BMA) showed hypercellular marrow with trilineage dysplastic features, micromegakaryocytes and 13% myeloblasts. A diagnosis of refractory cytopenia with multilineage dysplasia was given, based on the WHO MDS classification [1]. A trephine biopsy was in accordance with the results from the bone marrow aspirate with 15% myeloblasts displaying dyserythropoiesis and dysmegakaryopoiesis. Karyotype G banding Bax inhibitor peptide P5 analysis revealed a complex cytogenetic unusualness: 46, XX, del(5)(q14q34) [2]/49, sl, +1, +9, +11 [2]/52, sd1, +11, +22, +22 [16]. Based on the above data, high-risk MDS was regarded as. The patient underwent appropriate tests concerning eligibility for allogenic stem cell transplantation. The girl received the first cycle of 5-azacytidine at the conventional dosage of 75 mg/m2for 7 days from September 28, 2015. One week after starting 5-azacytidine, the girl developed moderate fever along with dry cough and, subsequently, her temperature rose to 39. 5 C. She was hospitalized on October 11, 2015. Vital signs and pulse oximetry were normal. She was placed under broad-spectrum antibiotics based on the protocol for febrile neutropenia, including ciprofloxacin 750 mg twice daily, ceftazidime 1 g three times daily (tid), and sulfamethoxazole/trimethoprim 400 mg/80 mg tid. Fever did not abate. All routine bacteriological investigations were unfavorable. Procalcitonin levels were within the normal range. The chest and sinus radiographs were normal, because were precipitins againstAspergillusand titers againstCytomegalovirus (CMV) and Epstein-Barr virus (EBV). CMV antigenemia was unfavorable. An interferon- release assay was unfavorable. Marrow re-aspiration revealed a 22% increment of blast number, suggesting a transformation towards acute myeloid leukemia. During her second week in hospital, the Mouse monoclonal to CD8.COV8 reacts with the 32 kDa a chain of CD8. This molecule is expressed on the T suppressor/cytotoxic cell population (which comprises about 1/3 of the peripheral blood T lymphocytes total population) and with most of thymocytes, as well as a subset of NK cells. CD8 expresses as either a heterodimer with the CD8b chain (CD8ab) or as a homodimer (CD8aa or CD8bb). CD8 acts as a co-receptor with MHC Class I restricted TCRs in antigen recognition. CD8 function is important for positive selection of MHC Class I restricted CD8+ T cells during T cell development patient complained of dyspnea on October 22, 2015. Blood gas showed a PaO2of 59 mmHg and PaCO2of 29 mmHg. Pulse oxygen saturation was 91% (room air). High-resolution computed tomography (HRCT) from the chest disclosed diffuse bilateral opacities with ground-glass shadowing and pleural effusion bilaterally (Fig. 1). Mediastinal and hilar lymph nodes were moderately enlarged. The patient was transferred to the intensive treatment unit on October 23 for bronchoalveolar lavage (BAL), which showed 170 red blood cells/mm3and 10 white blood cells/mm3. Polymerase chain reaction (PCR) forMycobacterium tuberculosis, Pneumocystis jiroveci, and CMV were unfavorable. Immunofluorescence test forPneumocystiswas also negative. Cultures including viral and fungal were all negative. The patient was maintained on antibiotics. A diagnosis of drug-induced pneumonitis was regarded as and, given the unfavorable BAL in terms of an infection, corticosteroid therapy was given at a dose of 1 mg/kg body weight on October 28. Within 4 days, a significant.